Cryolipolysis in the United States—Review of the clinical data

Abstract Background Noninvasive body contouring is becoming more popular in the United States as an alternative to liposuction. The most popular of these methods, cryolipolysis, uses precisely controlled cooling to reduce focal adiposities. The number of cryolipolysis procedures performed annually has experienced rampant growth in United States markets, and the indications have likewise diversified. In light of this change, it is imperative to perform an updated review of available US safety and efficacy data on cryolipolysis. Aims To examine the safety and efficacy of cryolipolysis treatments in the United States using data extracted from research performed exclusively at US‐based sites. Methods In order to identify relevant studies, a literature search was conducted on PubMed using the terms “CoolSculpting” OR “cryolipolysis” OR “lipocryolysis.” Articles were manually reviewed to exclude literature reviews, research not performed on humans, studies on experimental combinations of techniques, and any studies not performed in the United States. Results The initial literature search returned 246 results. Following manual review, a total of 18 studies were selected for data extraction. Mean reduction in fat thickness by ultrasound was 2.0–5.1 mm or 19.6%–32.3%; mean reduction by body caliper was 2.3–7 mm or 14.9%–21.5%. Side effects were mild and transient. Four instances of PAH were documented in 3453 treatment cycles. Conclusions Cryolipolysis is a safe, modestly effective method for reducing focal adiposity. Complications are rare and treatable. However, US‐based studies are few in number and often of low power and/or quality. More high‐quality research is needed for all aspects of cryolipolysis.